Cholinesterase group |  < 5000 U/L |  ≥ 5000 U/L, < 7000 U/L |  ≥ 7000 U/L | P value | P value* |
---|---|---|---|---|---|
No. of patients | 732 | 1103 | 552 | Â | Â |
Age (year) | 82.24 ± 6.39 | 79.23 ± 6.63 | 76.51 ± 6.23 |  < 0.001 |  < 0.001 |
Gender |  |  |  |  < 0.001 | - |
 Male | 285 (38.93%) | 372 (33.73%) | 124 (22.46%) |  |  |
 Female | 447 (61.07%) | 731 (66.27%) | 428 (77.54%) |  |  |
Occupation | Â | Â | Â | 0.296 | - |
 Retirement | 415 (56.69%) | 663 (60.11%) | 308 (55.80%) |  |  |
 Farmer | 183 (25.00%) | 257 (23.30%) | 132 (23.91%) |  |  |
 Other | 134 (18.31%) | 183 (16.59%) | 112 (20.29%) |  |  |
History of allergy | Â | Â | Â | 0.676 | - |
 No | 702 (95.90%) | 1055 (95.65%) | 533 (96.56%) |  |  |
 Yes | 30 (4.10%) | 48 (4.35%) | 19 (3.44%) |  |  |
Injury mechanism | Â | Â | Â | 0.025 | - |
 Falling | 702 (95.90%) | 1070 (97.01%) | 535 (96.92%) |  |  |
 Accident | 18 (2.46%) | 29 (2.63%) | 15 (2.72%) |  |  |
 Other | 12 (1.64%) | 4 (0.36%) | 2 (0.36%) |  |  |
Fracture classification |  |  |  |  < 0.001 | - |
 Intertrochanteric fracture | 593 (81.01%) | 793 (71.89%) | 319 (57.79%) |  |  |
 Femoral neck fracture | 119 (16.26%) | 282 (25.57%) | 221 (40.04%) |  |  |
 Subtrochanteric fracture | 20 (2.73%) | 28 (2.54%) | 12 (2.17%) |  |  |
aCCI |  |  |  |  < 0.001 | - |
 2 | 15 (2.05%) | 43 (3.90%) | 46 (8.33%) |  |  |
 3 | 75 (10.25%) | 241 (21.85%) | 148 (26.81%) |  |  |
 4 | 319 (43.58%) | 434 (39.35%) | 214 (38.77%) |  |  |
 5 | 214 (29.23%) | 268 (24.30%) | 101 (18.30%) |  |  |
 6 | 83 (11.34%) | 94 (8.52%) | 30 (5.43%) |  |  |
 7 | 24 (3.28%) | 17 (1.54%) | 12 (2.17%) |  |  |
 8 | 2 (0.27%) | 5 (0.45%) | 1 (0.18%) |  |  |
 9 | 0 (0.00%) | 1 (0.09%) | 0 (0.00%) |  |  |
Hypertension |  |  |  |  < 0.001 | - |
 No | 430 (58.74%) | 541 (49.05%) | 250 (45.29%) |  |  |
 Yes | 302 (41.26%) | 562 (50.95%) | 302 (54.71%) |  |  |
Diabetes |  |  |  |  < 0.001 | - |
 No | 629 (85.93%) | 872 (79.06%) | 408 (73.91%) |  |  |
 Yes | 103 (14.07%) | 231 (20.94%) | 144 (26.09%) |  |  |
CHD | Â | Â | Â | 0.034 | - |
 No | 317 (43.31%) | 545 (49.41%) | 265 (48.01%) |  |  |
 Yes | 415 (56.69%) | 558 (50.59%) | 287 (51.99%) |  |  |
Arrhythmia |  |  |  |  < 0.001 | - |
 No | 433 (59.15%) | 773 (70.08%) | 393 (71.20%) |  |  |
 Yes | 299 (40.85%) | 330 (29.92%) | 159 (28.80%) |  |  |
Hemorrhagic stroke | Â | Â | Â | 0.069 | - |
 No | 709 (96.86%) | 1083 (98.19%) | 544 (98.55%) |  |  |
 Yes | 23 (3.14%) | 20 (1.81%) | 8 (1.45%) |  |  |
Ischemic stroke | Â | Â | Â | 0.508 | - |
 No | 510 (69.67%) | 784 (71.08%) | 401 (72.64%) |  |  |
 Yes | 222 (30.33%) | 319 (28.92%) | 151 (27.36%) |  |  |
Cancer | Â | Â | Â | 0.042 | - |
 No | 701 (95.77%) | 1074 (97.37%) | 541 (98.01%) |  |  |
 Yes | 31 (4.23%) | 29 (2.63%) | 11 (1.99%) |  |  |
Associated injuries | Â | Â | Â | 0.035 | - |
 No | 666 (90.98%) | 1032 (93.56%) | 521 (94.38%) |  |  |
 Yes | 66 (9.02%) | 71 (6.44%) | 31 (5.62%) |  |  |
Dementia | Â | Â | Â | 0.001 | - |
 No | 686 (93.72%) | 1065 (96.55%) | 538 (97.46%) |  |  |
 Yes | 46 (6.28%) | 38 (3.45%) | 14 (2.54%) |  |  |
COPD | Â | Â | Â | 0.027 | - |
 No | 677 (92.49%) | 1028 (93.20%) | 530 (96.01%) |  |  |
 Yes | 55 (7.51%) | 75 (6.80%) | 22 (3.99%) |  |  |
Virus hepatitis | Â | Â | Â | 0.045 | - |
 No | 699 (95.49%) | 1071 (97.10%) | 540 (97.83%) |  |  |
 Yes | 33 (4.51%) | 32 (2.90%) | 12 (2.17%) |  |  |
Gastritis | Â | Â | Â | 0.617 | - |
 No | 717 (97.95%) | 1087 (98.55%) | 543 (98.37%) |  |  |
 Yes | 15 (2.05%) | 16 (1.45%) | 9 (1.63%) |  |  |
Treatment strategy |  |  |  |  < 0.001 | - |
 Conservation | 102 (13.93%) | 72 (6.53%) | 21 (3.80%) |  |  |
 ORIF | 514 (70.22%) | 756 (68.54%) | 317 (57.43%) |  |  |
 HA | 115 (15.71%) | 262 (23.75%) | 194 (35.14%) |  |  |
 THA | 1 (0.14%) | 13 (1.18%) | 20 (3.62%) |  |  |
Time to admission (h) | 122.38 ± 334.64 | 65.26 ± 211.11 | 52.07 ± 209.43 |  < 0.001 |  < 0.001 |
Time to operation (d) | 4.51 ± 2.93 | 4.19 ± 2.33 | 4.23 ± 2.43 | 0.035 | 0.091 |
Operation time (mins) | 97.84 ± 39.46 | 92.45 ± 36.96 | 95.05 ± 34.84 | 0.016 | 0.012 |
Blood loss (mL) | 261.97 ± 168.35 | 242.74 ± 153.89 | 229.21 ± 152.63 | 0.002 | 0.098 |
Infusion (mL) | 1543.74 ± 417.19 | 1558.61 ± 378.33 | 1611.81 ± 370.13 | 0.009 |  < 0.001 |
Transfusion (U) | 1.58 ± 1.29 | 1.10 ± 1.26 | 0.70 ± 1.09 |  < 0.001 |  < 0.001 |
Stay in hospital (d) | 9.17 ± 3.73 | 8.81 ± 3.83 | 8.56 ± 2.98 | 0.01 | 0.012 |
Follow-up (months) | 32.68 ± 19.62 | 39.94 ± 18.37 | 39.65 ± 15.98 |  < 0.001 |  < 0.001 |
Mortality |  |  |  |  < 0.001 | - |
 Survival | 354 (48.36%) | 801 (72.62%) | 445 (80.62%) |  |  |
 Dead | 378 (51.64%) | 302 (27.38%) | 107 (19.38%) |  |  |